FPH Appoints New Director and Future Director

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare appoints Anna Curzon to the Board as a non-executive director;
appoints Margie Apa as new Future Director participant

Auckland, New Zealand, 19 January 2026 - Fisher & Paykel Healthcare Corporation Limited announced
today it has appointed Anna Curzon to the Board to fill the vacancy following the retirement of Pip
Greenwood. Ms Curzon will join the Board as a non-executive director with effect from 1 February
2026.

Ms Curzon brings a wealth of knowledge in the technology and financial services industries and is a
member of the APEC Business Advisory Council.

Board Chair Neville Mitchell said, “Anna has had a strong international commercial career from a New
Zealand base. I look forward to her contributions to the Board.”

Currently, Ms Curzon is a director of Gallagher Holdings Limited, Kiwibank and Jade Software
Corporation and she chairs the board of Atomic.io. Over her 25-year career, Ms Curzon has served as
Managing Director NZ, Chief Partner Officer, and Chief Product Officer at Xero, and she has held
leadership or advisory roles with a number of other technology companies.

“Fisher & Paykel Healthcare is a leading med-tech company operating on the world stage, and it’s a
privilege to join the Board,” said Ms Curzon. “I’m excited to contribute to a business that plays such a
meaningful role in improving care and outcomes for millions of patients globally.”

The Fisher & Paykel Healthcare Board has determined that Ms Curzon will be an independent director.

Margie Apa appointed Future Director

Fisher & Paykel Healthcare has selected Margie Apa to participate in its Future Directors programme
with effect from 1 February 2026.

Ms Apa brings over 20 years of executive leadership experience in the health sector including as former
chief executive officer of Te Whatu Ora Health New Zealand and Counties Manukau Health. In those
roles, she led the provision and funding of hospital and community care. She also oversaw the merger
of 20 district health boards into a single national entity employing more than 90,000 people.

Ms Apa is currently on the board of World Vision International and is a trustee of World Vision New
Zealand.

Future Directors is a program aimed at giving talented executives exposure to a company board while
also providing boards with access to diverse talent, ideas and experiences. Future Directors attend
board meetings to observe and participate in discussions, but they do not have voting rights.

Board Chair Neville Mitchell said, “Fisher & Paykel Healthcare has been a longstanding supporter of the
Future Directors program and we believe we will benefit from Margie’s insights and leadership
experience in hospital and community care.”

Ms Apa said, “This is a great opportunity with an organisation that cares about improving the clinician
and patient experience. I look forward to contributing to Fisher & Paykel Healthcare.”



About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems
for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The
company’s products are sold in over 120 countries worldwide. For more information about the company,
visit our website www.fphcare.com.

Contacts:

Media Investors
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 (0) 21 713 911
Dan Adolph
Head of Investor Relations
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board Chair.